Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To determine whether surgery with adjuvant chemotherapy offers a survival advantage over concurrent chemoradiation for patients with cT1-2N0M0 small cell lung cancer (SCLC).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann. Surg.

Title: Annals of surgery

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1528-1140

ISSN (Print): 0003-4932

Publication date (Electronic): May 04 2017

Affiliations

[1 ] *Duke University Medical Center, Durham, NC †Department of Biostatistics and Bioinformatics, Duke University, Durham, NC ‡Stanford University Medical Center, Stanford, CA.

Article

DOI: 10.1097/SLA.0000000000002287

PubMed ID: 28475559

SO-VID: 49eda9aa-9a01-4a7d-a852-428e0402a804

History

Data availability:

Comments

Comment on this article

scite_

Cited by 43

See all cited by